Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Menlo Therapeutics Inc (MNLO)

Menlo Therapeutics Inc (MNLO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Menlo Therapeutics Inc 200 CARDINAL WAY 2ND FLOOR REDWOOD CITY CA 94063 USA

P: 650-486-1416

Description:

Menlo Therapeutics Inc. is a late stage biopharmaceutical company. It focused on the development of serlopitant and treatment of chronic itch and chronic refractory cough. The company's product pipeline consists of Prurigo Nodularis Itch, Atopic Dermatitis Itch, Psoriasis Itch and Refractory Chronic Cough which are in clinical stage. Menlo Therapeutics Inc. is headquartered in Redwood City, California.

Key Statistics

Overview:

Market Capitalization, $K 122,400
Shares Outstanding, K 23,953
Annual Sales, $ 10,640 K
Annual Net Income, $ -51,450 K
60-Month Beta 2.13
% of Insider Shareholders 5.50%
% of Institutional Shareholders 76.54%
Float, K 22,636
% Float 94.50%

Growth:

1-Year Return -13.61%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.76 on 02/27/19
Next Earnings Date 11/06/19
Earnings Per Share ttm -2.26
EPS Growth vs. Prev Qtr 14.81%
EPS Growth vs. Prev Year -91.67%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

MNLO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.50
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -53.16
Return-on-Assets (Before Tax) -49.14
Profit Margin % -483.55
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 11.30
Price/Cash Flow N/A
Price/Book 1.20
Book Value/Share 4.27
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar